<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: FRX News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=frx</link><description>Latest Financial News for FOREST LABS CL A</description><language>en-us</language><lastBuildDate>Thu, 24 Dec 2009 18:05:18 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>MedImmune responds to FDA on pediatric drug (at bizjournals.com)</title><link>http://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12gdmgdpi/*http%3A//washington.bizjournals.com/washington/stories/2009/12/21/daily52.html?ana=yfcpc</link><description></description><guid isPermaLink="false">yahoo_finance/547486207</guid><pubDate>Thu, 24 Dec 2009 18:05:18 Etc/GMT</pubDate></item><item><title>AZ and Forest tie up to buy Novexel (at FT.com)</title><link>http://us.rd.yahoo.com/finance/external/ft/rss/SIG=1258ldmqd/*http%3A//www.ft.com/cms/s/4626d016-f018-11de-833d-00144feab49a.html?referrer_id=yahoofinance&amp;ft_ref=yahoo1&amp;segid=03058</link><description>AstraZeneca and Forest, the UK and US pharmaceutical companies, are to pay up to $425m to buy Novexel, a private France-based drug company specialising in the development of antibiotics.</description><guid isPermaLink="false">yahoo_finance/3753517151</guid><pubDate>Thu, 24 Dec 2009 00:00:28 Etc/GMT</pubDate></item><item><title>[$$] AstraZeneca Agrees to Buy Novexel (at The Wall Street Journal Online)</title><link>http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=12iak4j1k/*http%3A//online.wsj.com/article/SB10001424052748704254604574613993686653678.html?ru=yahoo&amp;mod=yahoo_hs</link><description></description><guid isPermaLink="false">yahoo_finance/1209738597</guid><pubDate>Wed, 23 Dec 2009 23:08:52 Etc/GMT</pubDate></item><item><title>AstraZeneca buying Novexel, makes deal with Forest (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091223/us_astrazeneca_forest_acquisition.html?.v=1</link><description>AstraZeneca said Wednesday it will buy French drug developer Novexel for $350 million upfront, while also striking a deal giving Forest Laboratories development rights to Novexel&apos;s potential antibiotic booster.</description><guid isPermaLink="false">yahoo_finance/3875119832</guid><pubDate>Wed, 23 Dec 2009 19:08:15 Etc/GMT</pubDate></item><item><title>AstraZeneca To Buy Novexel (at Fox Business)</title><link>http://us.rd.yahoo.com/finance/external/FoxBusiness.com/rss/SIG=12stcffaj/*http%3A//www.foxbusiness.com/story/markets/industries/health-care/astrazeneca-buy-novexel/</link><description></description><guid isPermaLink="false">yahoo_finance/14019222</guid><pubDate>Wed, 23 Dec 2009 18:17:28 Etc/GMT</pubDate></item><item><title>UPDATE - Astra, Forest to develop combo antibiotics (at Reuters)</title><link>http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh80720_2009-12-23_16-10-18_n23219672_newsml&amp;rpc=44&amp;type=marketsNews</link><description></description><guid isPermaLink="false">yahoo_finance/279132435</guid><pubDate>Wed, 23 Dec 2009 16:10:18 Etc/GMT</pubDate></item><item><title>AstraZeneca to buy Novexel for $350 mln (at MarketWatch)</title><link>http://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=11kitjnkn/*http%3A//www.marketwatch.com/News/Story/Story.aspx?guid=%7b20D23C08-958A-4124-898E-5CB8408867F5%7d&amp;siteid=yhoof2</link><description></description><guid isPermaLink="false">yahoo_finance/787208295</guid><pubDate>Wed, 23 Dec 2009 15:17:33 Etc/GMT</pubDate></item><item><title>Forest Laboratories Announces Acquisition of Additional Rights Related to NXL 104, a Novel Broad-Spectrum Beta-Lactamase Inhibitor (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091223/20091223005276.html?.v=1</link><description>NEW YORK----Forest Laboratories announced today its agreement to acquire additional rights to NXL 104, which amends the terms of its prior agreement with Novexel covering the combination of NXL 104 with ceftaroline and adds additional rights to the combination of ceftazidime and NXL 104, through a transaction with AstraZeneca executed immediately following AstraZeneca’s announced acquisition of Novexel, S.A.</description><guid isPermaLink="false">yahoo_finance/139340769</guid><pubDate>Wed, 23 Dec 2009 15:00:00 Etc/GMT</pubDate></item><item><title>[$$] Congress Punts on the Estate Tax (at RealMoney by TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmpe/rss/SIG=12bq0d2dp/*http%3A//www.thestreet.com/p/_yahoo/rmoney/marketcommentary/10649052.html?cm_ven=YAHOO&amp;cm_cat=PREMIUM&amp;cm_ite=003190</link><description></description><guid isPermaLink="false">yahoo_finance/105777387</guid><pubDate>Fri, 18 Dec 2009 15:00:00 Etc/GMT</pubDate></item><item><title>Coverage initiated on Forest Labs by Soleil (Briefing.com)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/ud?s=FRX</link><description></description><guid isPermaLink="false">yahoo_finance/4211413871</guid><pubDate>Fri, 18 Dec 2009 12:44:27 Etc/GMT</pubDate></item><item><title>Forest Labs, Almirall to develop asthma drug (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091217/us_forest_laboratories_almirall.html?.v=2</link><description>Forest Laboratories Holdings Ltd. said Wednesday it will pay Spanish drug developer Almirall SA $75 million upfront to collaborate on a potential asthma treatment using an experimental Almirall drug.</description><guid isPermaLink="false">yahoo_finance/3788800965</guid><pubDate>Thu, 17 Dec 2009 22:05:26 Etc/GMT</pubDate></item><item><title>Invest Successfully and Still Have a Life (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=13460da75/*http%3A//www.fool.com/retirement/general/2009/12/17/invest-successfully-and-still-have-a-life.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/3881482816</guid><pubDate>Thu, 17 Dec 2009 21:01:16 Etc/GMT</pubDate></item><item><title>Almirall and Forest Laboratories to Expand Respiratory Collaboration with LAS100977 (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091217/20091216006337.html?.v=1</link><description>NEW YORK &amp; BARCELONA, Spain----Forest Laboratories Holdings, Ltd., a wholly owned subsidiary of Forest Laboratories, Inc. and Almirall, S.A. today announced that they have entered an agreement to develop, market and distribute LAS100977 in the United States.</description><guid isPermaLink="false">yahoo_finance/1065111467</guid><pubDate>Thu, 17 Dec 2009 07:30:00 Etc/GMT</pubDate></item><item><title>Prospecting for Stocks: Abbott Laboratories (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12kjsr8jg/*http%3A//www.fool.com/investing/general/2009/12/15/prospecting-for-stocks-abt.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/1910860467</guid><pubDate>Tue, 15 Dec 2009 18:48:45 Etc/GMT</pubDate></item><item><title>Stealth Generic Drug Play: 1 Minute Trade (TheStreet.com TV)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://cosmos.bcst.yahoo.com/up/finance?ch=633473&amp;cl=17132290&amp;lang=</link><description>&lt;summary&gt;&lt;![CDATA[NEW YORK (TheStreet) -- David Peltier discusses a generic drug stock that&apos;s still under the radar.]]&gt;&lt;/summary&gt;&lt;image&gt;http://us.news2.yimg.com/us.yimg.com/p/fi/26/39/43.jpg&lt;/image&gt;&lt;guid&gt;/yfinance/tscm/strategysession/10643905&lt;/guid&gt;&lt;link&gt;&lt;![CDATA[javascript:void(window.open(&apos;http://cosmos.bcst.yahoo.com/up/finance?ch=633473&amp;cl=17132290&amp;lang=&apos;,&apos;playerWindow&apos;,&apos;width=793,height=666,scrollbars=no&apos;));]]&gt;&lt;/link&gt;&lt;plink&gt;http://www.thestreet.com/&lt;/plink&gt;</description><guid isPermaLink="false">yahoo_finance/3061986412</guid><pubDate>Mon, 14 Dec 2009 14:04:36 Etc/GMT</pubDate></item><item><title>Forest Laboratories Announces Executive Exercised Stock Options with Intent to Hold Shares (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091211/20091211005750.html?.v=1</link><description>NEW YORK----Forest Laboratories, Inc. , announced today that Howard Solomon, Chairman and Chief Executive Officer exercised stock options for 1,200,000 shares which are expiring in December 2009 having reached the end of their 10-year term.</description><guid isPermaLink="false">yahoo_finance/123230846</guid><pubDate>Fri, 11 Dec 2009 21:29:00 Etc/GMT</pubDate></item><item><title>[video] Stealth Generic Drug Play: 1 Minute Trade (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/video/ts/rss/SIG=132v5r51s/*http%3A//www.thestreet.com/_yahoo/story/10643905/1/stealth-generic-drug-play-1-minute-trade.html?cm_ven=YAHOOV&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/1594800589</guid><pubDate>Fri, 11 Dec 2009 14:38:24 Etc/GMT</pubDate></item><item><title>Which Is the Better Opportunity: GlaxoSmithKline or Forest Labs? (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12kpvgotc/*http%3A//www.fool.com/investing/general/2009/12/09/prospecting-for-stocks-gsk.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/1459449191</guid><pubDate>Thu, 10 Dec 2009 01:38:01 Etc/GMT</pubDate></item><item><title>Forest Laboratories names Zimetbaum to board (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091209/us_forest_laboratories_personnel.html?.v=1</link><description>Drug developer Forest Laboratories Inc. said Wednesday it named Dr. Peter J. Zimetbaum to its board of directors. The appointment increases the size of the board to nine members.</description><guid isPermaLink="false">yahoo_finance/2640247519</guid><pubDate>Wed, 9 Dec 2009 20:26:58 Etc/GMT</pubDate></item><item><title>FOREST LABORATORIES INC Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091209/frx8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/2731300567</guid><pubDate>Wed, 9 Dec 2009 20:19:52 Etc/GMT</pubDate></item></channel></rss><!-- c3.finance.sp2.yahoo.com compressed/chunked Sat Dec 26 19:16:41 PST 2009 -->
